heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with cilostazol in 1 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (cilostazol) | Trials (cilostazol) | Recent Studies (post-2010) (cilostazol) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 1,508 | 302 | 848 |
| Protein | Taxonomy | heptakis(2,6-o-dimethyl)beta-cyclodextrin (IC50) | cilostazol (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 10 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.4367 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.3285 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, SG; Rajput, SJ | 1 |
1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and cilostazol
| Article | Year |
|---|---|
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Cilostazol; Cyclodextrins; Drug Stability; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Tetrazoles; X-Ray Diffraction | 2009 |